Cellnovo: Half-Yearly Report on the Liquidity Contract With CM-CIC Securities

Regulatory News:

Pursuant to the liquidity contract entrusted by CELLNOVO (Paris:CLNV) to CM-CIC Securities, as of December 31, 2015, the following assets appeared on the liquidity account:

• 8,036 shares CELLNOVO
• Cash balance of the liquidity account: €178,470.52

As a reminder, when the contract was implemented, the following resources were booked to the liquidity account:

• Cash balance of the liquidity account: €300,000

About Cellnovo

An independent medical technology company specialising in diabetes, Cellnovo has developed and markets the first mobile, connected all-in-one diabetes management system that helps make life easier for patients. Compact, tubeless, intuitive and entirely connected, Cellnovo’s insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient’s condition to be continually monitored by family members and healthcare professionals in real-time.

For further information please visit www.cellnovo.com

Cellnovo is listed on Euronext, Compartment C
ISIN: FR0012633360 – Ticker: CLNV

View source version on businesswire.com: http://www.businesswire.com/news/home/20160115005242/en/